NEWS!!!
Tuesday June 10 8:10 AM EDT
Company Press Release
ImmuDyne Inc. reports new arrangement with South American distributor
HOUSTON--(BW HealthWire)--June 10, 1997--ImmuDyne Inc. (OTC:BB - news) announced that, as a result of recent meetings at Harbor Branch Oceanographic Institution in Florida between ImmuDyne management and Max Rutman, the director of TEPUAL S.A., the previously agreed upon order of $4.5 million has been canceled.
TEPUAL is continuing its product testing to find the best combinations of feed utilizing ImmuStim(TM) in shrimp and other animal species with the intention of marketing these products as they are proven.
TEPUAL will begin distribution of ImmuDyne's ImmuStim(TM) Immersion Concentrate for the aquaculture industry in its international markets in September 1997, and is investigating opportunities in the ornamental fish market as well.
As noted in ImmuDyne's press release of Jan. 23, 1997, the contract had not yet resulted in sales, but the companies have continued to work together.
Although both companies regret that the original purchase order was not completed, there is agreement that there are opportunities for both companies to work together for mutual profit through distribution of ImmuStim(TM) Immersion Concentrate and additional products after ongoing studies have determined the most efficacious combinations of nutritional supplements in various species.
TEPUAL S.A. is a Chilean company specializing in marine protein and animal health and nutrition. They are a major world supplier of high quality marine protein with annual exports in excess of $150 million per year to major international companies such as Ralston Purina, Marubeni, Mitsubishi and Nohara in Japan, Rainbow Chicken Farms in South Africa, and F.K. in Norway, as well as companies in Europe and Latin America.
TEPUAL is the single largest supplier of high quality marine protein to the Japanese aquaculture industry, and the world leader in Antarctic krill meal production.
ImmuDyne Inc. is traded on the NASD Automated Bulletin Board under the symbol IMMD. ImmuDyne Inc. is a Texas-based biotechnology company specializing in macrophage technology. It has proprietary technology relating to immune system stimulants for cosmetic, human nutritional, animal nutritional and aquacultural use. ImmuDyne Inc. maintains offices in Houston and Palo Alto, Calif.
For more information on the company, contact Margaret Dreyfus, 415 949-3864, or visit its website at www.immudyne.com . |
